Profile data is unavailable for this security.
About the company
Attana AB is a Sweden-based biotechnology company specializing in in vitro characterization of molecular interactions mimicking in vivo conditions. The Company develops proprietary label-free biosensors, based on the Quartz Crystal Microbalance (QCM) technology, for biochemical, crude, sera and cell-based assays. Its products and research services are used by pharmaceutical and biotechnology companies to quality control the production line of a biological pharmaceutical or gain insight into advanced dynamic features of target molecules, as well as by academic institutions within the life sciences. Attana’s biosensors are used to determine specificity, kinetics and affinity, among other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.
- Revenue in SEK (TTM)4.10m
- Net income in SEK-12.78m
- Incorporated2013
- Employees6.00
- LocationAttana ABGreta Arwidssons vag 21STOCKHOLM 114 19SwedenSWE
- Phone+46 841020000
- Websitehttps://www.attana.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PCI Biotech Holding ASA | 4.49m | -19.68m | 4.99m | 7.00 | -- | 0.4161 | -- | 1.11 | -0.5502 | -0.5502 | 0.1256 | 0.3353 | 0.1676 | -- | 0.896 | 669,714.30 | -73.44 | -41.44 | -92.22 | -46.61 | -- | -- | -438.10 | -897.91 | -- | -- | 0.022 | -- | 125.25 | -6.43 | 19.19 | -- | -- | -- |
| Respiratorius AB (publ) | 0.00 | -6.95m | 10.19m | -- | -- | 0.3331 | -- | -- | -1.15 | -1.15 | 0.00 | 3.87 | 0.00 | -- | -- | -- | -22.10 | -- | -22.91 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 8.10 | -- | -- | -- |
| Stayble Therapeutics AB | 0.00 | -6.93m | 11.49m | 2.00 | -- | 1.66 | -- | -- | -0.1227 | -0.1227 | 0.00 | 0.1076 | 0.00 | -- | -- | -- | -77.50 | -74.45 | -89.43 | -84.74 | -- | -- | -- | -- | -- | -3,463.50 | 0.1094 | -- | -- | -- | 44.21 | -- | -- | -- |
| Novakand Pharma AB | 0.00 | -47.23m | 14.45m | 5.00 | -- | 0.9589 | -- | -- | -0.3897 | -0.3897 | 0.00 | 0.1243 | 0.00 | -- | -- | 0.00 | -112.94 | -58.37 | -122.10 | -66.37 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -5.98 | -- | -- | -- |
| Fluicell AB | 6.00m | -8.33m | 15.52m | 11.00 | -- | 1.42 | -- | 2.59 | -6.06 | -6.06 | 4.37 | 7.94 | 0.2729 | -2.23 | 7.04 | 545,636.40 | -37.89 | -81.30 | -54.89 | -120.68 | 218.79 | 135.50 | -138.82 | -549.48 | 0.6019 | -- | -- | -- | 222.86 | 5.31 | 46.28 | -- | 92.14 | -- |
| Lumito AB (publ) | 0.00 | -43.83m | 15.98m | 8.00 | -- | 0.2108 | -- | -- | -20.88 | -20.88 | 0.00 | 22.03 | 0.00 | -0.1054 | -- | 0.00 | -43.82 | -28.18 | -51.99 | -31.47 | -- | 41,896.64 | -- | -167,207.40 | 1.49 | -20.34 | 0.0733 | -- | -100.00 | -- | -5.72 | -- | -44.20 | -- |
| Gabather AB | 0.00 | -4.65m | 16.13m | 2.00 | -- | -- | -- | -- | -0.0384 | -0.0384 | 0.00 | -0.0111 | 0.00 | -- | -- | 0.00 | -209.07 | -67.13 | -- | -90.59 | -- | -- | -- | -- | -- | -76.57 | -- | -- | -- | -- | 17.84 | -- | -- | -- |
| Peptonic Medical AB | 15.69m | -48.98m | 22.41m | 3.00 | -- | 0.3207 | -- | 1.43 | -0.0068 | -0.0068 | 0.002 | 0.0037 | 0.1994 | 0.6491 | 3.47 | 2,242,000.00 | -62.23 | -52.80 | -86.90 | -72.84 | 67.85 | 54.48 | -312.10 | -141.78 | 0.2747 | -26.44 | 0.2863 | -- | -27.55 | 43.57 | -40.95 | -- | 11.04 | -- |
| ATTANA AB | 4.10m | -12.78m | 23.23m | 6.00 | -- | 0.6845 | -- | 5.66 | -0.0154 | -0.0154 | 0.0047 | 0.0132 | 0.1425 | -0.7611 | 1.02 | 656,600.00 | -44.37 | -37.91 | -61.34 | -48.09 | 161.16 | 189.23 | -311.34 | -305.50 | 0.6079 | -3.79 | 0.1315 | -- | -18.77 | -8.69 | 7.33 | -- | 8.51 | -- |
| Aptahem AB | 0.00 | -7.43m | 26.61m | -- | -- | 0.2164 | -- | -- | -0.6711 | -0.6711 | 0.00 | 3.77 | 0.00 | -- | -- | -- | -11.21 | -30.70 | -11.57 | -34.24 | -- | -- | -- | -- | -- | -44.15 | 0.00 | -- | -- | -- | 22.90 | -- | 88.99 | -- |
| Guard Therapeutics Intrntnl AB (publ) | 0.00 | -108.85m | 32.27m | 5.00 | -- | 0.7942 | -- | -- | -6.43 | -6.43 | 0.00 | 2.01 | 0.00 | -- | -- | -- | -198.12 | -84.57 | -265.33 | -96.74 | -- | -- | -- | -- | -- | -64.77 | -- | -- | -- | -- | -13.31 | -- | -- | -- |
| Strategic Partners A/S | 0.00 | -4.80m | 34.84m | 1.00 | -- | 1.34 | -- | -- | -83.43 | -83.43 | 0.00 | 433.01 | 0.00 | -- | -- | 0.00 | -18.16 | -66.13 | -19.52 | -94.41 | -- | -- | -- | -- | -- | -69.91 | 0.00 | -- | -- | -- | 98.86 | -- | -- | -- |
